Manjiri M. Bakre

1.1k total citations
32 papers, 822 citations indexed

About

Manjiri M. Bakre is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Manjiri M. Bakre has authored 32 papers receiving a total of 822 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cancer Research, 12 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Manjiri M. Bakre's work include Breast Cancer Treatment Studies (20 papers), HER2/EGFR in Cancer Research (10 papers) and Breast Lesions and Carcinomas (7 papers). Manjiri M. Bakre is often cited by papers focused on Breast Cancer Treatment Studies (20 papers), HER2/EGFR in Cancer Research (10 papers) and Breast Lesions and Carcinomas (7 papers). Manjiri M. Bakre collaborates with scholars based in India, United States and Singapore. Manjiri M. Bakre's co-authors include Judith A. Varner, Semi Kim, Hong Yin, Lawrence W. Stanton, Sandhya S. Visweswariah, Jamie Mong, Yuin‐Han Loh, Yixun Li, Xi Chen and Weiwei Zhang and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Manjiri M. Bakre

29 papers receiving 810 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manjiri M. Bakre India 14 515 205 199 135 82 32 822
Paraskevi Alexandrou Greece 18 497 1.0× 280 1.4× 390 2.0× 105 0.8× 67 0.8× 43 922
Yin Xu United States 11 600 1.2× 173 0.8× 230 1.2× 87 0.6× 80 1.0× 15 858
Dawid G. Nowak United States 12 952 1.8× 242 1.2× 167 0.8× 65 0.5× 61 0.7× 20 1.2k
Eadaoin McKiernan Ireland 9 401 0.8× 175 0.9× 271 1.4× 97 0.7× 29 0.4× 11 689
Kym L. Stanley Australia 9 588 1.1× 123 0.6× 310 1.6× 134 1.0× 37 0.5× 10 893
Arusha Oloumi Canada 11 694 1.3× 325 1.6× 249 1.3× 133 1.0× 179 2.2× 12 1.0k
Kathy A. Toy United States 17 666 1.3× 340 1.7× 358 1.8× 54 0.4× 91 1.1× 19 999
Stéphanie Gout France 11 492 1.0× 167 0.8× 249 1.3× 125 0.9× 38 0.5× 11 722
Martine Charbonneau Canada 14 397 0.8× 266 1.3× 178 0.9× 57 0.4× 56 0.7× 19 827
Baek Gil Kim South Korea 20 602 1.2× 374 1.8× 410 2.1× 112 0.8× 33 0.4× 31 1.0k

Countries citing papers authored by Manjiri M. Bakre

Since Specialization
Citations

This map shows the geographic impact of Manjiri M. Bakre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manjiri M. Bakre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manjiri M. Bakre more than expected).

Fields of papers citing papers by Manjiri M. Bakre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manjiri M. Bakre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manjiri M. Bakre. The network helps show where Manjiri M. Bakre may publish in the future.

Co-authorship network of co-authors of Manjiri M. Bakre

This figure shows the co-authorship network connecting the top 25 collaborators of Manjiri M. Bakre. A scholar is included among the top collaborators of Manjiri M. Bakre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manjiri M. Bakre. Manjiri M. Bakre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ghosh, Susmita, et al.. (2025). CanAssist Breast-based prognostication in low-intermediate estrogen receptor positive (ER 1%–20% ) early-stage breast cancer patients helps guide treatment decisions. Therapeutic Advances in Medical Oncology. 17. 22786954–22786954. 1 indexed citations
3.
Bakre, Manjiri M., et al.. (2025). Real-world data of CanAssist Breast- first immunohistochemistry and AI-based prognostic test. Scientific Reports. 15(1). 30430–30430. 1 indexed citations
4.
Eshwaraiah, Mallikarjuna Siraganahalli, et al.. (2023). The usefulness of CanAssist Breast over Ki67 in breast cancer recurrence risk assessment. Cancer Medicine. 12(12). 13342–13351. 2 indexed citations
5.
Zhang, Xi, Elma Meershoek‐Klein Kranenbarg, Gerrit‐Jan Liefers, et al.. (2023). Ten-year distant-recurrence risk prediction in breast cancer by CanAssist Breast (CAB) in Dutch sub-cohort of the randomized TEAM trial. Breast Cancer Research. 25(1). 40–40. 8 indexed citations
6.
Eshwaraiah, Mallikarjuna Siraganahalli, et al.. (2022). A comparative analysis of recurrence risk predictions in ER+/HER2− early breast cancer using NHS Nottingham Prognostic Index, PREDICT, and CanAssist Breast. Breast Cancer Research and Treatment. 196(2). 299–310. 6 indexed citations
7.
Doval, Dinesh Chandra, Anurag Mehta, S. P. Somashekhar, et al.. (2021). The usefulness of CanAssist breast in the assessment of recurrence risk in patients of ethnic Indian origin. The Breast. 59. 1–7. 11 indexed citations
8.
Sengupta, Aditya K., et al.. (2020). Comparison of breast cancer prognostic tests CanAssist Breast and Oncotype DX. Cancer Medicine. 9(21). 7810–7818. 14 indexed citations
9.
11.
Jain, Jugnu, Lakshmipathi Khandrika, Akshay Avula, et al.. (2016). Epidemiological and survival analysis of triple-negative breast cancer cases in a retrospective multicenter study. Indian Journal of Cancer. 53(3). 353–353. 14 indexed citations
12.
Stanton, Lawrence W. & Manjiri M. Bakre. (2007). Genomic and proteomic characterization of embryonic stem cells. Current Opinion in Chemical Biology. 11(4). 399–404. 11 indexed citations
13.
Loh, Yuin‐Han, Weiwei Zhang, Yixun Li, et al.. (2007). Zic3 Is Required for Maintenance of Pluripotency in Embryonic Stem Cells. Molecular Biology of the Cell. 18(4). 1348–1358. 114 indexed citations
14.
Kim, Semi, et al.. (2002). Inhibition of endothelial cell survival and angiogenesis by protein kinase A. Journal of Clinical Investigation. 110(7). 933–941. 6 indexed citations
15.
Kim, Semi, Manjiri M. Bakre, Hong Yin, & Judith A. Varner. (2002). Inhibition of endothelial cell survival and angiogenesis by protein kinase A. Journal of Clinical Investigation. 110(7). 933–941. 128 indexed citations
16.
Kim, Semi, Manjiri M. Bakre, Hong Yin, & Judith A. Varner. (2002). Inhibition of endothelial cell survival and angiogenesis by protein kinase A. Journal of Clinical Investigation. 110(7). 933–941. 135 indexed citations
17.
Bakre, Manjiri M., et al.. (2002). Assaying G Protein–Phosphodiesterase Interactions in Sensory Systems. Methods in enzymology on CD-ROM/Methods in enzymology. 345. 37–48. 6 indexed citations
18.
Bakre, Manjiri M., Yuhong Zhu, Hong Yin, et al.. (2002). Parathyroid hormone–related peptide is a naturally occurring, protein kinase A–dependent angiogenesis inhibitor. Nature Medicine. 8(9). 995–1003. 81 indexed citations
19.
Bakre, Manjiri M., Yashoda Ghanekar, & Sandhya S. Visweswariah. (2000). Homologous desensitization of the human guanylate cyclase C receptor. European Journal of Biochemistry. 267(1). 179–187. 26 indexed citations
20.
Bakre, Manjiri M. & Sandhya S. Visweswariah. (1997). Dual regulation of heat‐stable enterotoxin‐mediated cGMP accumulation in T84 cells by receptor desensitization and increased phosphodiesterase activity. FEBS Letters. 408(3). 345–349. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026